XML 32 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
OPERATING EXPENSES:    
Amortization $ 57,344 $ 57,344
Research and development expenses 2,845,594 100,914
Selling, general and administrative expenses 2,644,346 228,497
TOTAL OPERATING EXPENSES 5,547,284 386,755
LOSS FROM OPERATIONS (5,547,284) (386,755)
OTHER EXPENSE (INCOME) EXPENSE:    
Change in fair value of derivative liabilities (8,279,919)
Interest expense 1,114 559,312
Interest income (7,645) (64)
TOTAL OTHER INCOME, NET (6,531) (7,720,671)
NET (LOSS)/INCOME (5,540,753) 7,333,916
Deemed dividends - related party 53,598,320
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (5,540,753) $ (46,264,404)
- Basic $ (0.23) $ (7.75)
- Diluted $ (0.23) $ (7.75)
- Basic 23,719,927 5,971,622
- Diluted 23,719,927 5,971,622